摘要：

This invention, the nervous disease which it is related to nervous metabolism decrease, for example the Alzheimer's disease and the parkinson's disease, the huridoraihi ataxia symptom (FRDA), the GLUT1 scarcity characteristic epilepsy, repurekonizumu and rabuson - mendenhoru syndrome, aorta crown artery bypass transplantation (CABG) the acknowledgment symptom, anesthesia inviting occurrence amnesia and age increase characteristic dysmnesia (AAMI), the external wound characteristic brain injury (the THROUGH-BULKHEAD INITIATOR), remedies the hanchinton illness, and the other many disease, in order prevention, you control or to lighten, or, regards the mono glyceride of aceto acetate and the method of using the metabolism precursor.< Selective figure >Figure 1B

展开